Last reviewed · How we verify
Spinal administration of chloroprocaine.
Spinal administration of chloroprocaine. is a Small molecule drug developed by University Hospital, Ghent. It is currently FDA-approved.
At a glance
| Generic name | Spinal administration of chloroprocaine. |
|---|---|
| Sponsor | University Hospital, Ghent |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Flex Appeal: Evaluating the Efficacy of Anesthetic Techniques for Manipulation of Knees Under Anesthesia (PHASE4)
- Comparative Analysis of Spinal Anesthesia Versus General Anesthesia for vNOTES (NA)
- Mechanisms and Treatment of Post-amputation Neuropathic Pain (NA)
- Determination of the Minimum Local Analgesic Dose of Spinal Chloroprocaine in Labour (PHASE4)
- Spinal or Intravenous Dexmedetomidine in Ambulatory Surgery (PHASE4)
- Intrathecal Paracetamol Before Spinal Anaesthesia With Chloroprocaine HCl 1% for Short Knee Procedures (PHASE2)
- Decision Support for Intraoperative Low Blood Pressure (NA)
- Chloroprocaine for Inguinal Herniorrhaphy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Spinal administration of chloroprocaine. CI brief — competitive landscape report
- Spinal administration of chloroprocaine. updates RSS · CI watch RSS
- University Hospital, Ghent portfolio CI
Frequently asked questions about Spinal administration of chloroprocaine.
What is Spinal administration of chloroprocaine.?
Spinal administration of chloroprocaine. is a Small molecule drug developed by University Hospital, Ghent.
Who makes Spinal administration of chloroprocaine.?
Spinal administration of chloroprocaine. is developed and marketed by University Hospital, Ghent (see full University Hospital, Ghent pipeline at /company/university-hospital-ghent).
What development phase is Spinal administration of chloroprocaine. in?
Spinal administration of chloroprocaine. is FDA-approved (marketed).